Waterdrop Inc. (WDH) - Form 20-F Summary
Business Context and Reporting Period
This summary covers Waterdrop Inc.'s Annual Report on Form 20-F for the fiscal year ended December 31, 2024. Waterdrop is a Cayman Islands holding company operating primarily in mainland China through Variable Interest Entities (VIEs). The company operates a technology platform providing insurance brokerage services, medical crowdfunding, and digital clinical trial solutions. As of December 31, 2024, VIEs contributed 83.4% of total net revenues.
Key Financial Metrics (Year Ended Dec 31, 2024)
| Metric | 2024 (RMB) | 2024 (US$) | 2023 (RMB) | Change (YoY) |
|---|---|---|---|---|
| Net Operating Revenue | 2,771,821 | 379,738 | 2,630,707 | +5.4% |
| Net Profit | 350,883 | 48,069 | 163,685 | +114.3% |
| Operating Profit | 178,158 | 24,407 | (6,743) | Turnaround to Profit |
| Operating Margin | 6.4% | 6.4% | -0.3% | +6.7 pts |
| Cash from Operations | 437,250 | 59,904 | 406,516 | +7.6% |
| Total Assets | 6,453,665 | 884,146 | 6,148,663 | +4.9% |
| Cash & Equivalents | 986,323 | 135,126 | 396,905 | +148.5% |
| Short-term Loans | 198,373 | 27,177 | 137,557 | +44.2% |
Note: US$ amounts are translated at RMB 7.2993 = US$1.00.
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased 5.4% driven by a 64.5% surge in crowdfunding service fees (RMB 267.7 million) and a 1.0% increase in insurance-related income. First Year Premiums (FYP) rose to RMB 7.47 billion.
- Profitability Turnaround: The company returned to operating profitability (RMB 178.2 million) from an operating loss of RMB 6.7 million in 2023. This was achieved through effective cost control, reducing total operating expenses by 1.7% despite revenue growth.
- Expense Reduction: Research and Development expenses dropped 27.6% (RMB 216.5 million) due to reduced personnel costs. Sales and marketing expenses decreased 6.2% (RMB 694.8 million) despite increased third-party traffic channel investments, offset by lower personnel costs.
- Liquidity Improvement: Cash and cash equivalents more than doubled to RMB 986.3 million, supported by strong operating cash flow and a shift in investment strategy (net cash provided by investing activities was RMB 291.6 million).
- Dividends: The company paid special cash dividends totaling approximately US$22.1 million in 2024 (US$0.04/ADS in March and US$0.02/ADS in September).
Guidance, Outlook, and Risks
Management Commentary: Management attributes the improved results to the optimization of long-term insurance product offerings, the acquisition of Shenlanbao (consolidated since July 2023), and cost optimization measures. The company continues to invest in AI technologies ("Waterdrop Guardian") to enhance operational efficiency and user experience.
Key Risks and Contingencies:
- VIE Structure Risk: As a Cayman holding company with no direct equity in Chinese operating entities, the company relies on contractual arrangements. Changes in PRC law could render these unenforceable, potentially leading to deconsolidation of VIEs (which represent 83.4% of revenue).
- Regulatory Environment: The company faces evolving regulations in China regarding insurance brokerage, medical crowdfunding, and data privacy. Recent designations by the Ministry of Civil Affairs for the crowdfunding platform are positive, but regulatory scrutiny remains high.
- PCAOB/HFCAA: While the PCAOB currently has access to inspect auditors in mainland China, future inability to do so could lead to delisting risks under the Holding Foreign Companies Accountable Act (HFCAA).
- Concentration Risk: Revenue is concentrated in the insurance brokerage segment (85.3% of total revenue). The company relies on relationships with insurance carriers, some of which represent significant portions of revenue.
Investor Verification Checklist
- VIE Contractual Enforceability: Verify the status of contractual arrangements with VIEs and any recent PRC regulatory actions affecting similar structures.
- Insurance Carrier Concentration: Review the top 5 insurance carriers by revenue contribution to assess dependency risks.
- Regulatory Compliance: Confirm the status of licenses for insurance brokerage and the newly designated medical crowdfunding platform status.
- Dividend Sustainability: Assess the ability of mainland China subsidiaries to generate distributable profits given statutory reserve requirements and potential withholding taxes.
- AI Investment ROI: Monitor the commercialization progress and cost-benefit analysis of the "Waterdrop Guardian" AI initiatives.